BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9103675)

  • 1. Transcription factors of the bHLH and LIM families: synergistic mediators of T cell acute leukemia?
    Baer R; Hwang LY; Bash RO
    Curr Top Microbiol Immunol; 1997; 220():55-65. PubMed ID: 9103675
    [No Abstract]   [Full Text] [Related]  

  • 2. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.
    Baer R
    Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intertwining proteins in thymocyte development and cancer.
    Murre C
    Nat Immunol; 2000 Aug; 1(2):97-8. PubMed ID: 11248796
    [No Abstract]   [Full Text] [Related]  

  • 4. The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells.
    Valge-Archer VE; Osada H; Warren AJ; Forster A; Li J; Baer R; Rabbitts TH
    Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8617-21. PubMed ID: 8078932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL.
    Ono Y; Fukuhara N; Yoshie O
    J Biol Chem; 1997 Feb; 272(7):4576-81. PubMed ID: 9020185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.
    Ferrando AA; Neuberg DS; Staunton J; Loh ML; Huard C; Raimondi SC; Behm FG; Pui CH; Downing JR; Gilliland DG; Lander ES; Golub TR; Look AT
    Cancer Cell; 2002 Feb; 1(1):75-87. PubMed ID: 12086890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. V(D)J-mediated translocations in lymphoid neoplasms: a functional assessment of genomic instability by cryptic sites.
    Marculescu R; Le T; Simon P; Jaeger U; Nadel B
    J Exp Med; 2002 Jan; 195(1):85-98. PubMed ID: 11781368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cellular differentiation by the SCL/tal oncoprotein: transcriptional repression by an Id-like mechanism.
    Goldfarb AN; Lewandowska K
    Blood; 1995 Jan; 85(2):465-71. PubMed ID: 7812000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primitive erythropoiesis in the Xenopus embryo: the synergistic role of LMO-2, SCL and GATA-binding proteins.
    Mead PE; Deconinck AE; Huber TL; Orkin SH; Zon LI
    Development; 2001 Jun; 128(12):2301-8. PubMed ID: 11493549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice.
    O'Neil J; Billa M; Oikemus S; Kelliher M
    Oncogene; 2001 Jun; 20(29):3897-905. PubMed ID: 11439353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LIM domain proteins in leukaemia and development.
    Sánchez-García I; Rabbitts TH
    Semin Cancer Biol; 1993 Dec; 4(6):349-58. PubMed ID: 8142620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell acute lymphoblastic leukemia and the associated basic helix-loop-helix gene SCL/tal.
    Goldfarb AN; Greenberg JM
    Leuk Lymphoma; 1994 Jan; 12(3-4):157-66. PubMed ID: 8167548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The stem cell leukaemia (SCL) gene: a critical regulator of haemopoietic and vascular development.
    Barton LM; Göttgens B; Green AR
    Int J Biochem Cell Biol; 1999 Oct; 31(10):1193-207. PubMed ID: 10582347
    [No Abstract]   [Full Text] [Related]  

  • 14. Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice.
    Chervinsky DS; Zhao XF; Lam DH; Ellsworth M; Gross KW; Aplan PD
    Mol Cell Biol; 1999 Jul; 19(7):5025-35. PubMed ID: 10373552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SCL/TAL1 gene: roles in normal and malignant haematopoiesis.
    Robb L; Begley CG
    Bioessays; 1997 Jul; 19(7):607-13. PubMed ID: 9230693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic-specific genes are not induced during in vitro differentiation of scl-null embryonic stem cells.
    Elefanty AG; Robb L; Birner R; Begley CG
    Blood; 1997 Aug; 90(4):1435-47. PubMed ID: 9269761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3.
    Ono Y; Fukuhara N; Yoshie O
    Mol Cell Biol; 1998 Dec; 18(12):6939-50. PubMed ID: 9819382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoallelic or biallelic LMO2 expression in relation to the LMO2 rearrangement status in pediatric T-cell acute lymphoblastic leukemia.
    Van Vlierberghe P; Beverloo HB; Buijs-Gladdines J; van Wering ER; Horstmann M; Pieters R; Meijerink JP
    Leukemia; 2008 Jul; 22(7):1434-7. PubMed ID: 18079736
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of the V(D)J recombination efficiency at lymphoid chromosomal translocation breakpoints.
    Raghavan SC; Kirsch IR; Lieber MR
    J Biol Chem; 2001 Aug; 276(31):29126-33. PubMed ID: 11390401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice.
    Larson RC; Lavenir I; Larson TA; Baer R; Warren AJ; Wadman I; Nottage K; Rabbitts TH
    EMBO J; 1996 Mar; 15(5):1021-7. PubMed ID: 8605871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.